The key to successful advisory research is outstanding content development, project management, meeting moderation, logistical support, and reporting.

Advisory Boards

 


IN-PERSON ADVISORY BOARDS
Exceptional Solutions Through Expert Insight

In-person advisory board meetings provide a valuable opportunity for our clients to gain actionable insights, feedback, and recommendations directly from healthcare experts. Clearly delineated goals and objectives provide a foundation upon which we work to recruit advisors and create meeting content. Our project management team meticulously plans and implements all of the logistical requirements; transportation, hotel, meeting room, audio visual, and banquet facilities. Professional moderation is used to optimize the use of time and focus discussion on high priority questions. Our in-person meetings are integrated with surveys, pre-meeting assignments, polling, and breakout groups to maximize productivity and advisor participation.

See our approach to KOL identification.

See our list of key advisory board topic areas.

 


VIRTUAL ADVISORY BOARDS
On-line Meetings to Gain Expert Insight

A virtual advisory board meeting (VAB) requires fewer resources (e.g., cost, time, travel, etc.), but can provide great value if designed and implemented well. We often recommend using a VAB when the meeting must be completed quickly and/or there is a limited budget. A VAB can be an appropriate solution when the number of objectives and KOLs can be limited. Our VABs are integrated with pre-meeting assignments and live polling to maximize productivity and advisor participation.

See our article on virtual advisory board meetings.

 


DISCUSSION GROUPS
Regional Peer-to-Peer Roundtable Discussions

Discussion Groups allow our clients to obtain insights in a less formal setting, facilitated by IFI and/or a KOL. These small discussion groups may be conducted as an independent dinner program or onsite at a professional association meeting. This is a platform through which insights are derived from discussion among healthcare professionals and used to uncover geographical differences. IFI will work with you to develop content and identify the most appropriate KOL to lead the discussion.

 

KOL ID

Our Meticulous Approach to KOL Identification

KOL ID is used to identify highly qualified key opinion leaders (KOLs) who are best suited to support the clinical and commercial development of a new or existing product or indication. The goal is to prioritize these KOLs for engagement in advisory board meetings, publications, speaker programs, clinical research or regulatory meetings.

KOL ID begins with a development plan, which specifies activities that will benefit from KOL participation as well as the qualifications required to support each activity. We evaluate background information, and use a customized algorithm to weight qualifications to generate a prioritized list of KOL nominees. In collaboration with you, a final prioritized list of KOLs is created for each activity.

The four key steps of the KOL ID process are:

   
Planning
  • Initial plan
  • Segmentation
  • Create algorithm
   
Identification
  • Secondary research
  • Networking
  • Experience
                 
   
Assessment
  • Evaluate data
  • Apply algorithm
  • Draft priorities
   
Prioritization
  • Establish consensus
  • Finalize list 

Key Advisory Board Topic Areas:

  • Clinical Practice
    To assess current clinical practice patterns and unmet needs, and identify programs and tools to support successful product adoption and utilization.
  • Clinical Research
    To obtain critical feedback on clinical development plans, clinical study protocols and key study parameters.
  • Health Outcomes
    To obtain feedback on health economics and outcomes research (HEOR) plans, and key parameters of HEOR models and studies.
  • Regulatory
    To obtain feedback on regulatory pathways and key requirements (eg, REMS/RMP) for approval of new products and indications.
  • Mechanism of Action (MOA)
    To generate clear and concise explanations of the mechanism of action of a new product, and its relationship to the pathophysiology of the target medical disorder.
  • Market Access
    To identify the information required to establish product differentiation and support the value of a new product leading to successful payer and channel strategies.